| |
| | PA Bulletin, Doc. No. 04-1917 |
 | | The Board heard the petitions of the Office of Attorney General which requested that 1-(3--trifluorometh- ylphenyl) Piperazine (TFMPP), N-Benzylpiperazine (BZP), Alpha-Methyltryptamine (AMT), 2, 5 Dimethoxy--4-(N)--Propylthiophenethylamine, and 5--Methoxy--N, N--Di- isopropyltryptamine (5-MEO-DIPT) be scheduled as Schedule I controlled substances. |
 | | The substances 1-(3--trifluoromethylphenyl) Piperazine (TFMPP), N-Benzylpiperazine (BZP), Alpha-Methyl- tryptamine (AMT), 2, 5 Dimethoxy--4-(N)--Propyl- thiophenethylamine, and 5--Methoxy--N, N--Diiso- propyltryptamine (5-MEO-DIPT) would be scheduled as Schedule I. Affected Persons |
 | | The act recognizes the fact that there is a need to control substances which have potential for abuse while also recognizing that some of those substances have medical uses. |
| www.pabulletin.com /secure/data/vol34/34-43/1917.html (1184 words) |
|